Biotron publishes SARS research
Thursday, 11 November, 2004
The researchers at Biotron and the John Curtin School of Medical Research at ANU showed that the SARS coronavirus E protein forms ion channels.
Based on the research, Biotron has developed a screening test for the E protein and has screened its compound library for activity against the SARS E protein as well as other members of the coronavirus family, which are responsible for about 25 per cent of colds as well as other diseases. The company has identified a number of compounds with good activity, which are able to inhibit the replication of the SARS virus.
The work has been supported by a Commonwealth government BIF grant awarded to Biotron in November last year to support the development of the company's Virion platform technology.
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
